Early research (Phase 1)Study completedNCT00366418
What this trial is testing
Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic Leukemia
Who this might be right for
Refractory Chronic Lymphocytic Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 4